Navigation Links
EnVivo Pharmaceuticals Announces Executive Appointment
Date:9/26/2007

as we progress our pipeline and are seeking to further broaden our pipeline in the next two years," said Kees Been, President and Chief Executive Officer.

EnVivo Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs for central nervous system (CNS) disorders including, Alzheimer's disease, Parkinson's disease, Huntington's disease and Spino Cerebellar Ataxias. The company's lead programs include a Nicotinic Acetylcholine Receptor Agonist Program (alpha-7) for Alzheimer's disease and Schizophrenia, a Histone Deacetylase (HDAC) program for Huntington's disease, EVP2442 program for neuron-protection and the PDE10 inhibitor and gamma- secretase modulator programs. For more information see http://www.envivopharma.com


'/>"/>
SOURCE EnVivo Pharmaceuticals, Inc.,
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 Pacific Biomarkers and Clinigene International ... developers of biosimilars at the 2013 AAPS/ National ... Diego Hotel and Marina , ... the opportunity to speak with company representatives at their ... Cross" on May 21 from 1-2 p.m. in the ...
(Date:5/20/2013)... BALTIMORE , May 20, 2013 /PRNewswire/ ... private-public partnership focusing on commercializing market-relevant biohealth innovations ... Central Maryland , today announced its ... first Entrepreneur-in-Residence (EIR) for BHI at the National ... and Blood Institute (NHLBI). Dr. Aiyar will ...
(Date:5/20/2013)... 2013   Flexion Therapeutics , Inc. today announced ... to its management team as chief financial officer. ... management experience with biotechnology and medical device companies. ... financial officer for Novavax (NASDAQ: NVAX ) ... $250 million through a combination of investment funding and ...
(Date:5/20/2013)... May 20, 2013 Interventional cardiologist Tony ... General Hospital (AGH) Cardiovascular Institute have helped pioneer ... artery disease (CAD) over the past three decades, ... balloon angioplasty and coronary artery stent implantation. , Today, ... play a prominent role in the study of a ...
Breaking Biology Technology:Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4
... Cellectis (Alternext: ALCLS), the French genome engineering specialist, announces today ... Cellectis, approaches on vectors for meganucleases and genome surgery at the 13th ... held at the Marriott Wardman Park Hotel in Washington, USA , ... , , ...
... ,, TAIZHOU, China , ... Ltd.,one of the world,s leading biotechnology companies focusing on ... China Medical City (CMC) opened, China,s state-of-the-art stem ... Stem Cell Regenerative Medicine Industrial Project of,National Bio-Industry Base ...
... , , ... /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), ... cancer, today announced the dosing of the first patient under the ... in prostate cancer patients. The study will evaluate the localization, safety, ...
Cached Biology Technology:Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting 2Beike Biotechnology Opens World's Largest Stem Cell Storage and Processing Facility 2Beike Biotechnology Opens World's Largest Stem Cell Storage and Processing Facility 3Beike Biotechnology Opens World's Largest Stem Cell Storage and Processing Facility 4Beike Biotechnology Opens World's Largest Stem Cell Storage and Processing Facility 5Quest PharmaTech Announces Dosing Of First Patient In Its Prostate Cancer Clinical Trial 2Quest PharmaTech Announces Dosing Of First Patient In Its Prostate Cancer Clinical Trial 3
(Date:5/19/2013)... white men and women of European descent inherit common ... toe deformities, including hammer or claw toe. Findings from ... of foot disorders in humansappear in Arthritis Care ... behalf of the American College of Rheumatology (ACR). ... of older adults have foot disorders which may limit ...
(Date:5/19/2013)... at the University of California, Davis have engineered a ... for light. They report their findings today at ... Microbiology. , "In this work, we used synthetic biology ... carbon dioxide and light energy for growth) cyanobacterial metabolism ... Jordan McEwen, the lead researcher on the study. ...
(Date:5/18/2013)... (May 18, 2013) Research presented today at Digestive ... research, with findings about the impact of coffee on ... , While coffee consumption recently has been associated with ... even a few more cups of java each month ... liver disease. Researchers at the Mayo Clinic, Rochester, MN, ...
Breaking Biology News(10 mins):Blame your parents for bunion woes 2Coffee consumption associated with reduced risk of autoimmune liver disease 2
... complex feat of nanoengineering, a team of scientists at ... in creating a programable molecular transport system, the workings ... results, appearing in the latest issue of Nature ... advanced drug delivery methods and molecular manufacturing systems. ...
... Pharmaceuticals, illicit drugs, shampoo, toothpaste, pesticides, chemical run-off ... giant aquifer under Mexico,s "Riviera Maya," research shows. ... water-filled caves under the popular tourist destination on ... through the caves and into the Caribbean Sea. ...
... the days of Darwin, the "tree of life" has been ... gradual branching and changing of individual species. The discovery ... directly from one species of fungus to another, however, significantly ... mosaic, may be more appropriate. "The fungi are telling ...
Cached Biology News:Pollutants in aquifers may threaten future of Mexico's fast-growing 'Riviera Maya' 2Pollutants in aquifers may threaten future of Mexico's fast-growing 'Riviera Maya' 3Discovery of jumping gene cluster tangles tree of life 2Discovery of jumping gene cluster tangles tree of life 3
Mouse monoclonal antibody raised against a partial recombinant CHD8. NCBI Entrez Gene ID = CHD8...
... raised against a partial recombinant ... TOPORS (NP_005793, 98 a.a. ... protein with GST tag. ... NM_005802 Protein ...
Mouse monoclonal antibody raised against a partial recombinant DENR. NCBI Entrez Gene ID = DENR...
Mouse monoclonal antibody raised against a full length recombinant SNAPC5. NCBI Entrez Gene ID = SNAPC5...
Biology Products: